Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Fusobacterium spp. and colorectal cancer: cause or consequence?

Keku TO, McCoy AN, Azcarate-Peril AM.

Trends Microbiol. 2013 Oct;21(10):506-8. doi: 10.1016/j.tim.2013.08.004. Epub 2013 Sep 9.

2.

Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.

Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW.

Cell Host Microbe. 2013 Aug 14;14(2):195-206. doi: 10.1016/j.chom.2013.07.012.

3.

Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, El-Omar EM, Brenner D, Fuchs CS, Meyerson M, Garrett WS.

Cell Host Microbe. 2013 Aug 14;14(2):207-15. doi: 10.1016/j.chom.2013.07.007.

4.

Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.

Nosho K, Sukawa Y, Adachi Y, Ito M, Mitsuhashi K, Kurihara H, Kanno S, Yamamoto I, Ishigami K, Igarashi H, Maruyama R, Imai K, Yamamoto H, Shinomura Y.

World J Gastroenterol. 2016 Jan 14;22(2):557-66. doi: 10.3748/wjg.v22.i2.557. Review.

5.

Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.

Bashir A, Miskeen AY, Bhat A, Fazili KM, Ganai BA.

Eur J Cancer Prev. 2015 Sep;24(5):373-85. doi: 10.1097/CEJ.0000000000000116. Review.

PMID:
25569450
6.

Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.

Mima K, Sukawa Y, Nishihara R, Qian ZR, Yamauchi M, Inamura K, Kim SA, Masuda A, Nowak JA, Nosho K, Kostic AD, Giannakis M, Watanabe H, Bullman S, Milner DA, Harris CC, Giovannucci E, Garraway LA, Freeman GJ, Dranoff G, Chan AT, Garrett WS, Huttenhower C, Fuchs CS, Ogino S.

JAMA Oncol. 2015 Aug;1(5):653-61. doi: 10.1001/jamaoncol.2015.1377.

7.

Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.

Leung A, Tsoi H, Yu J.

Expert Rev Gastroenterol Hepatol. 2015 May;9(5):651-7. doi: 10.1586/17474124.2015.1001745. Epub 2015 Jan 12. Review.

PMID:
25582922
8.

Fusobacterium and Enterobacteriaceae: important players for CRC?

Allen-Vercoe E, Jobin C.

Immunol Lett. 2014 Dec;162(2 Pt A):54-61. doi: 10.1016/j.imlet.2014.05.014. Epub 2014 Jun 24. Review.

9.

[How some commensal bacteria would exacerbate colorectal carcinogenesis?].

Raisch J, Dalmasso G, Bonnet R, Barnich N, Bonnet M, Bringer MA.

Med Sci (Paris). 2016 Feb;32(2):175-82. doi: 10.1051/medsci/20163202011. Epub 2016 Mar 2. Review. French.

10.

Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.

Ito M, Kanno S, Nosho K, Sukawa Y, Mitsuhashi K, Kurihara H, Igarashi H, Takahashi T, Tachibana M, Takahashi H, Yoshii S, Takenouchi T, Hasegawa T, Okita K, Hirata K, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y.

Int J Cancer. 2015 Sep 15;137(6):1258-68. doi: 10.1002/ijc.29488. Epub 2015 Mar 13.

11.

Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.

Yu YN, Yu TC, Zhao HJ, Sun TT, Chen HM, Chen HY, An HF, Weng YR, Yu J, Li M, Qin WX, Ma X, Shen N, Hong J, Fang JY.

Oncotarget. 2015 Oct 13;6(31):32013-26. doi: 10.18632/oncotarget.5166.

12.

Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut.

Bashir A, Miskeen AY, Hazari YM, Asrafuzzaman S, Fazili KM.

Tumour Biol. 2016 Mar;37(3):2805-10. doi: 10.1007/s13277-015-4724-0. Epub 2015 Dec 30. Review.

PMID:
26718210
13.

Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.

Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA.

Genome Res. 2012 Feb;22(2):299-306. doi: 10.1101/gr.126516.111. Epub 2011 Oct 18.

14.

Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth.

Coppenhagen-Glazer S, Sol A, Abed J, Naor R, Zhang X, Han YW, Bachrach G.

Infect Immun. 2015 Mar;83(3):1104-13. doi: 10.1128/IAI.02838-14. Epub 2015 Jan 5.

15.

Fusobacterium nucleatum: a commensal-turned pathogen.

Han YW.

Curr Opin Microbiol. 2015 Feb;23:141-7. doi: 10.1016/j.mib.2014.11.013. Epub 2015 Jan 8. Review.

16.

Identification and characterization of a novel adhesin unique to oral fusobacteria.

Han YW, Ikegami A, Rajanna C, Kawsar HI, Zhou Y, Li M, Sojar HT, Genco RJ, Kuramitsu HK, Deng CX.

J Bacteriol. 2005 Aug;187(15):5330-40.

17.

Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.

Chen S, Liu J, Li G, Mo F, Xu X, Zhang T, Zhang X, Li J, Han X, Sun Y.

Scand J Gastroenterol. 2008;43(4):456-64. doi: 10.1080/00365520701785194.

PMID:
18365911
18.
19.

Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.

Lian J, Tang J, Shi H, Li H, Zhen T, Xie W, Zhang F, Yang Y, Han A.

Oncotarget. 2015 Oct 6;6(30):29357-74. doi: 10.18632/oncotarget.4982.

20.

Detection of fusobacterium nucleatum and fadA adhesin gene in patients with orthodontic gingivitis and non-orthodontic periodontal inflammation.

Liu P, Liu Y, Wang J, Guo Y, Zhang Y, Xiao S.

PLoS One. 2014 Jan 9;9(1):e85280. doi: 10.1371/journal.pone.0085280. eCollection 2014.

Supplemental Content

Support Center